XML 39 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair value of financial instruments and marketable securities (Tables)
9 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities that are required to be measured at fair value on a recurring basis
The following represents the fair value using the hierarchy described above for the Company’s financial assets and liabilities that are required to be measured at fair value on a recurring basis as of September 30, 2018 and December 31, 2017:
 
 
September 30, 2018
 
 
Total
 
Quoted prices
in active
markets for
identical assets
(level 1)
 
Significant
other
observable
inputs
(level 2)
 
Significant
unobservable
inputs
(level 3)
Marketable securities
 
$
42,491

 
$

 
$
42,491

 
$

Warrant liability
 
$
4

 
$

 
$

 
$
4

Stock appreciation rights liability
 
$
3,463

 
$

 
$

 
$
3,463

Deferred consideration payable
 
$
38,200

 
$

 
$
38,200

 
$

Contingent consideration payable
 
$
218,700

 
$

 
$

 
$
218,700

 
 
December 31, 2017
 
 
Total
 
Quoted prices
in active
markets for
identical assets
(level 1)
 
Significant
other
observable
inputs
(level 2)
 
Significant
unobservable
inputs
(level 3)
Marketable securities
 
$
79,454

 
$

 
$
79,454

 
$

Warrant Liability
 
$
1

 
$

 
$

 
$
1

Stock appreciation rights liability
 
$
1,665

 
$

 
$

 
$
1,665

Deferred consideration payable

 
$

 
$

 
$

 
$

Contingent consideration payable
 
$

 
$

 
$

 
$

Summary of marketable securities accounted for as available-for-sale securities
The following is a summary of marketable securities accounted for as available-for-sale securities at September 30, 2018 and December 31, 2017:
 
 
September 30, 2018
 
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
 
 
Gains
 
Losses
 
Commercial paper
 
$
18,441

 
$

 
$
(6
)
 
$
18,435

Corporate debt securities
 
24,078

 
2

 
(24
)
 
24,056

 
 
$
42,519

 
$
2

 
$
(30
)
 
$
42,491

 
 
December 31, 2017
 
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
 
 
Gains
 
Losses
 
Commercial paper
 
$
13,775

 
$
52

 
$

 
$
13,827

Corporate debt securities
 
65,657

 

 
(30
)
 
65,627

 
 
$
79,432

 
$
52

 
$
(30
)
 
$
79,454

Summary of unrealized losses and fair values of available-for-sale securities in a continuous unrealized loss position
The unrealized losses and fair values of available-for-sale securities that have been in an unrealized loss position for a period of less than and greater than 12 months as of September 30, 2018 are as follows:
 
 
September 30, 2018
 
 
Securities in an unrealized loss position less than 12 months
 
Securities in an unrealized loss position greater than 12 months
 
Total
 
 
Unrealized losses
 
Fair Value
 
Unrealized losses
 
Fair Value
 
Unrealized losses
 
Fair Value
Commercial paper
 
$
(6
)
 
$
18,435

 
$

 
$

 
$
(6
)
 
$
18,435

Corporate debt securities
 
(24
)
 
18,067

 

 

 
(24
)
 
18,067

 
 
$
(30
)
 
$
36,502

 
$

 
$

 
$
(30
)
 
$
36,502

The unrealized losses and fair values of available-for-sale securities that have been in an unrealized loss position for a period of less than and greater than 12 months as of December 31, 2017 are as follows:
 
 
December 31, 2017
 
 
Securities in an unrealized loss position less than 12 months
 
Securities in an unrealized loss position greater than 12 months
 
Total
 
 
Unrealized losses
 
Fair Value
 
Unrealized losses
 
Fair Value
 
Unrealized losses
 
Fair Value
Corporate debt securities
 
$
(28
)
 
$
59,108

 
$
(2
)
 
$
6,519

 
$
(30
)
 
$
65,627

Schedule of marketable securities on the balance sheet
Marketable securities on the balance sheet at September 30, 2018 and December 31, 2017 mature as follows:
 
 
September 30, 2018
 
 
Less Than
12 Months
 
More Than
12 Months
Commercial paper
 
$
18,435

 
$

Corporate debt securities
 
24,056

 

Total Marketable securities
 
$
42,491

 
$

 
 
December 31, 2017
 
 
Less Than
12 Months
 
More Than
12 Months
Commercial paper
 
$
13,827

 
$

Corporate debt securities
 
55,550

 
10,077

Total Marketable securities
 
$
69,377

 
$
10,077

Summary of changes in the fair value of the Company's Level 3 valuation for warrant liability and SARs liability
The table presented below is a summary of changes in the fair value of the Company’s Level 3 valuations for the warrant liability, the SARs liability, and the contingent consideration payable for the period ended September 30, 2018:
 
 
Level 3 liabilities
 
 
Warrants
 
SARs
 
Contingent consideration payable
Beginning balance as of December 31, 2017
 
$
1

 
$
1,665

 
$

Additions
 

 

 
218,700

Change in fair value
 
3

 
3,789

 

Payments
 

 
(1,991
)
 
$

Ending balance as of September 30, 2018
 
$
4

 
$
3,463

 
$
218,700